Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID ▲ | Title | Descriptor |
|---|---|---|---|
| 2C4F | P13726 | crystal structure of factor VII.stf complexed with pd0297121 | COAGULATION FACTOR VII PRECURSOR (E.C.3.4.21.21), TISSUE FACTOR PRECURSOR |
| 2EC9 | P13726 | Crystal structure analysis of human Factor VIIa , Souluble tissue factor complexed with BCX-3607 | |
| 2FIR | P13726 | Crystal structure of DFPR-VIIa/sTF | Coagulation factor VII Light chain (E.C.3.4.21.21), Coagulation factor VII Heavy Chain (EC 3.4.21.21), Tissue factor |
| 2PUQ | P13726 | Crystal structure of active site inhibited coagulation factor VIIA in complex with soluble tissue factor | |
| 2ZP0 | P13726 | Human factor viia-tissue factor complexed with benzylsulfonamide-D-ile-gln-P-aminobenzamidine | |
| 2ZWL | P13726 | Human factor viia-tissue factor complexed with highly selective peptide inhibitor | |
| 2ZZU | P13726 | Human Factor VIIA-Tissue Factor Complexed with ethylsulfonamide-D-5-(3-carboxybenzyloxy)-Trp-Gln-p-aminobenzamidine | |
| 3ELA | P13726 | Crystal structure of active site inhibited coagulation factor VIIA mutant in complex with soluble tissue factor | |
| 3TH2 | P13726 | Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+ | |
| 3TH3 | P13726 | Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+ | |
| 3TH4 | P13726 | Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+ | |
| 4IBL | P13726 | Rubidium Sites in Blood Coagulation Factor VIIa | |
| 4YLQ | P13726 | Crystal Structure of a FVIIa-Trypsin Chimera (FT) in Complex with Soluble Tissue Factor | |
| 4Z6A | P13726 | Crystal Structure of a FVIIa-Trypsin Chimera (YT) in Complex with Soluble Tissue Factor | |
| 4ZMA | P13726 | Crystal Structure of a FVIIa-Trypsin Chimera (ST) in Complex with Soluble Tissue Factor | |
| 6R2W | P13726 | Crystal structure of the super-active FVIIa variant VYT in complex with tissue factor | |
| 8CN9 | P13726 | Factor VII binding Fab of the bispecific antibody HMB-001 in complex with Factor VII | |
| 2BRS | P13727 | EMBP Heparin complex | |
| 7Y5N | P13727 | Structure of 1:1 PAPP-A.ProMBP complex(half map) | |
| 4ATV | P13738 | STRUCTURE OF A TRIPLE MUTANT OF THE NHAA DIMER, CRYSTALLISED AT LOW PH | |
| 4AU5 | P13738 | Structure of the NhaA dimer, crystallised at low pH | |
| 1DLH | P13758 | CRYSTAL STRUCTURE OF THE HUMAN CLASS II MHC PROTEIN HLA-DR1 COMPLEXED WITH AN INFLUENZA VIRUS PEPTIDE | HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ANTIGENIC PEPTIDE |
| 6BIJ | P13760 | HLA-DRB1 in complex with citrullinated fibrinogen peptide | |
| 6BIV | P13760 | HLA-DRB1 in complex with citrullinated LL37 peptide | |
| 6V0Y | P13760 | immune receptor complex | |
| 6BIL | P13760 | HLA-DRB1 in complex with citrullinated fibrinogen peptide | |
| 6NIX | P13760 | Crystal structure of Immune Receptor | |
| 6V1A | P13760 | immune receptor complex | |
| 6BIN | P13760 | HLA-DRB1 in complex with Type II collagen peptide | |
| 6V15 | P13760 | immune receptor complex | |
| 6V19 | P13760 | immune receptor complex | |
| 6V18 | P13760 | immune receptor complex | |
| 1D5M | P13760 | X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDE AND SEB | |
| 1J8H | P13760 | Crystal Structure of a Complex of a Human alpha/beta-T cell Receptor, Influenza HA Antigen Peptide, and MHC Class II Molecule, HLA-DR4 | |
| 2SEB | P13760 | X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH A PEPTIDE FROM HUMAN COLLAGEN II | |
| 4MCY | P13760 | Immune Receptor | |
| 4MCZ | P13760 | Immune Receptor | |
| 4MD0 | P13760 | Immune Receptor | |
| 4MD4 | P13760 | Immune Receptor | |
| 4MD5 | P13760 | Immune Receptor | |
| 4MDI | P13760 | Immune Receptor | |
| 4MDJ | P13760 | Immune Receptor | |
| 4Y19 | P13760 | immune complex | |
| 4Y1A | P13760 | immune complex | HLA-DRA, HLA-DRB1.0401, ProinsulinC19 , FS17_alpha, FS17_beta |
| 6V13 | P13760 | immune receptor complex | |
| 4I0P | P13765 | HLA-DO in complex with HLA-DM | |
| 6JP5 | P13806 | Rabbit Cav1.1-Nifedipine Complex | |
| 6JPA | P13806 | Rabbit Cav1.1-Verapamil Complex | |
| 6JP8 | P13806 | Rabbit Cav1.1-Bay K8644 Complex | |
| 6JPB | P13806 | Rabbit Cav1.1-Diltiazem Complex |
